FOR INTRAVENOUS USE ONLY IN THE HORSE.
For specific information about the time which must elapse between treatment and competition, veterinary surgeons are advised to consult the authority responsible for the competition in question (e.g. the Jockey Club in the case of racing in the UK).
Do not exceed the stated dose or the duration of treatment.
Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects.
Do not use in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastro-intestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia or hypersensitivity to the product.
Use in any animal less than 6 weeks of age, or in aged animals may involve additional risk. If such use cannot be avoided, animals may require a reduced dosage and careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal as there is a potential risk of increased renal toxicity.
In horses, concurrent administration of potential nephrotoxic drugs should be avoided.
Studies in cattle have suggested a transient nodule unassociated with heat or pain may form at the site of injection, although it is felt that this may be related to needle trauma rather than the product and has only been seen in a small number of animals.
In the absence of any specific studies in pregnant target animals, such use is not indicated.
There is no specific antidote for carprofen overdosage but general supportive therapy as applied to clinical overdosage with NSAIDs should be applied.
Avoid skin contact with the product. Wash off any splashes immediately. Take care to avoid accidental self-injection.
For animal treatment only.
Withdrawal period
Cattle – Meat – 21 days; milk not for use in cattle producing milk for human consumption. Horses: This product is not intended for use in horses for human consumption.
